Visitdress+Hausera specialist in process instrumentation, has acquired a stake in Finesse Solutionsa US company that develops, produces and distributes sensors, hardware and software for bioengineering.
Through this cooperation, Endress+Hauser intends to strengthen its position in biotechnology. " Biotechnological procedures will play an increasingly important role in the future, not only in the life sciences industry but also in all other industries, such as the chemical industry, in order to manufacture products in a more economical and environmentally-friendly way. "says Klaus Endress, Chairman and CEO of the Endress Group. Endress+Hauser. " Our partnership with Finesse gives us the opportunity to gain experience in this field without neglecting our core business. ".
The previous majority shareholder, Skymoon Ventureswill hold an interest equal to that ofEndress+Hauser. The company's staff of around 50 will retain their stake in the company. Endress+Hauser will elect two representatives to the Board of Directors, which Barbara A Paldus will continue to chair.
Learn more: www.fr.endress.com/